Nirvana Life Sciences Inc. (CNSX: NIRV.X)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
Nirvana Life Sciences Inc. (CNSX: NIRV.X) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $828.44K.
trading between 0.01 and 0.14.
Tweenvest scores Nirvana Life Sciences Inc. across four factors: quality 16/100, value 71/100. Its strongest factor is value.
NIRV.X price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $828.44K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -0.93
- 52-week high
- CA$0.14
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 22.92M
- Employees
- —
- Next earnings
- —
About Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics. It also focuses on developing methodologies for extraction and purification of psychoactive compounds; and the improvement of propagation techniques for growing such biomass on a large scale. The company was incorporated in 2020 and is headquartered in Vancouver, Canada.
- ISIN
- CA6546522054
- Listed since
- Mar 18, 2022
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kaya Holdings, Inc.OTCPK: KAYS | $892.36K | $0.00 | +1200.00% |
| Rimrock Gold Corp.OTCPK: RMRK | $865.21K | $0.00 | +56.25% |
| Aoxing Pharmaceutical Company, Inc.OTCPK: AOXG | $838.66K | $0.00 | +4.76% |
| RAMM Pharma Corp.CNSX: RAMM | $837.81K | CA$0.01 | +100.00% |
| Ovation Science Inc.CNSX: OVAT | $822.49K | CA$0.03 | +50.00% |
| Adastra Holdings Ltd.CNSX: XTRX | $815.78K | CA$— | — |
| Hemo Organic LimitedBSE: 524590 | $790.01K | Rs21.88 | +4.99% |
| SOL Global Investments Corp.CNSX: SOL | $764.92K | CA$— | — |
Figures last refreshed Oct 4, 2026.